Skip to content
Abbott
-
Seychelles and Eritrea adopt Abbott’s triple elimination test for maternal health
Abbott’s Determine™ ANC Panel enables simultaneous detection of HIV, syphilis, and hepatitis B from a single finger-prick sample, delivering results within minutes at the point of care.
-
Abbott secures CE mark for world’s first glucose-ketone wearable
The approval strengthens Abbott’s position in the continuous glucose monitoring (CGM) market and expands its diagnostic capabilities beyond glucose-only tracking, which has traditionally defined wearable diabetes management tools.
-
Abbott’s new CardioMEMS HERO Heart Failure Reader wins FDA approval
Abbott engineered the HERO reader to be 60% lighter than its predecessor, making it practical for daily use and convenient enough for patients to carry during travel.